Zobrazeno 1 - 10
of 89
pro vyhledávání: '"RN Eskander"'
Autor:
F Heitz, A Oaknin, FJ Backes, E Van Nieuwenhuysen, RN Eskander, A González-Martín, V Makker, C Marth, M Patel, RT Penson, A Redondo, MJR Pérez, E Hamilton, P Wimberger, N Concin, J Go, K Wride, D Lepley, R Dusek, T Cameron, S Pignata
Publikováno v:
64. Kongress der Deutschen Gesellschaft für Gynäkologie und Geburtshilfe e. V..
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e467c6b417f1afc6fe6efa11c32a396c
https://doi.org/10.1055/s-0042-1756856
https://doi.org/10.1055/s-0042-1756856
Autor:
Erickson BK; Department of Obstetrics, Gynecology, and Women's Health, University of Minnesota, Minneapolis, Minnesota, USA., Slomovitz B; Division of Gynecologic Oncology, Mount Sinai Medical Center, Miami Beach, Florida, USA., Powell M; Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Washington University School of Medicine, St. Louis, Missouri, USA., Eskander RN; Division of Gynecologic Oncology, Department of Obstetrics, Gynecology and Reproductive Sciences, University of California, San Diego Moores Cancer Center, La Jolla, California, USA.
Publikováno v:
Cancer [Cancer] 2024 Jul 15; Vol. 130 (14), pp. 2409-2412. Date of Electronic Publication: 2024 Apr 15.
ARID1A suppresses R-loop-mediated STING-type I interferon pathway activation of anti-tumor immunity.
Autor:
Maxwell MB; Molecular and Cell Biology Laboratory, Salk Institute for Biological Studies, La Jolla, CA 92037, USA; Biological Sciences Graduate Program, University of California, San Diego, La Jolla, CA 92092, USA; NOMIS Center for Immunobiology and Microbial Pathogenesis, Salk Institute for Biological Studies, La Jolla, CA 92037, USA., Hom-Tedla MS; Molecular and Cell Biology Laboratory, Salk Institute for Biological Studies, La Jolla, CA 92037, USA; Department of Gynecologic Oncology, University of California, San Diego, San Diego, CA, USA., Yi J; Molecular and Cell Biology Laboratory, Salk Institute for Biological Studies, La Jolla, CA 92037, USA., Li S; Molecular and Cell Biology Laboratory, Salk Institute for Biological Studies, La Jolla, CA 92037, USA; Biological Sciences Graduate Program, University of California, San Diego, La Jolla, CA 92092, USA; NOMIS Center for Immunobiology and Microbial Pathogenesis, Salk Institute for Biological Studies, La Jolla, CA 92037, USA., Rivera SA; Molecular and Cell Biology Laboratory, Salk Institute for Biological Studies, La Jolla, CA 92037, USA; Biological Sciences Graduate Program, University of California, San Diego, La Jolla, CA 92092, USA; NOMIS Center for Immunobiology and Microbial Pathogenesis, Salk Institute for Biological Studies, La Jolla, CA 92037, USA., Yu J; Integrative Genomics and Bioinformatics Core, Salk Institute of Biological Studies, La Jolla, CA 92037, USA., Burns MJ; Molecular and Cell Biology Laboratory, Salk Institute for Biological Studies, La Jolla, CA 92037, USA., McRae HM; Molecular and Cell Biology Laboratory, Salk Institute for Biological Studies, La Jolla, CA 92037, USA., Stevenson BT; Molecular and Cell Biology Laboratory, Salk Institute for Biological Studies, La Jolla, CA 92037, USA., Coakley KE; Molecular and Cell Biology Laboratory, Salk Institute for Biological Studies, La Jolla, CA 92037, USA; Department of Gynecologic Oncology, University of California, San Diego, San Diego, CA, USA., Ho J; Molecular and Cell Biology Laboratory, Salk Institute for Biological Studies, La Jolla, CA 92037, USA., Gastelum KB; Molecular and Cell Biology Laboratory, Salk Institute for Biological Studies, La Jolla, CA 92037, USA., Bell JC; Molecular and Cell Biology Laboratory, Salk Institute for Biological Studies, La Jolla, CA 92037, USA., Jones AC; Molecular and Cell Biology Laboratory, Salk Institute for Biological Studies, La Jolla, CA 92037, USA., Eskander RN; Center for Personalized Cancer Therapy and Division of Gynecologic Oncology, Department of Obstetrics, Gynecology and Reproductive Sciences, UC San Diego Moores Cancer Center, La Jolla, CA, USA., Dykhuizen EC; Department of Medicinal Chemistry and Molecular Pharmacology, Purdue University, West Lafayette, IN 47907, USA., Shadel GS; Molecular and Cell Biology Laboratory, Salk Institute for Biological Studies, La Jolla, CA 92037, USA; NOMIS Center for Immunobiology and Microbial Pathogenesis, Salk Institute for Biological Studies, La Jolla, CA 92037, USA., Kaech SM; NOMIS Center for Immunobiology and Microbial Pathogenesis, Salk Institute for Biological Studies, La Jolla, CA 92037, USA., Hargreaves DC; Molecular and Cell Biology Laboratory, Salk Institute for Biological Studies, La Jolla, CA 92037, USA; NOMIS Center for Immunobiology and Microbial Pathogenesis, Salk Institute for Biological Studies, La Jolla, CA 92037, USA. Electronic address: dhargreaves@salk.edu.
Publikováno v:
Cell [Cell] 2024 Jun 20; Vol. 187 (13), pp. 3390-3408.e19. Date of Electronic Publication: 2024 May 15.
Autor:
Patel-Lippmann KK; Vanderbilt University Medical Center, Nashville, Tennessee. Electronic address: krupa.k.patel-lippmann@vumc.org., Wasnik AP; Panel Chair, University of Michigan, Ann Arbor, Michigan., Akin EA; The George Washington University Medical Center, Washington, District of Columbia; Commission on Nuclear Medicine and Molecular Imaging., Andreotti RF; Vanderbilt University Medical Center, Nashville, Tennessee; O-RADS Committee., Ascher SM; MedStar Georgetown University Hospital, Washington, District of Columbia., Brook OR; Beth Israel Deaconess Medical Center, Boston, Massachusetts., Eskander RN; University of California, San Diego, San Diego, California; American College of Obstetricians and Gynecologists., Feldman MK; Cleveland Clinic, Cleveland, Ohio., Jones LP; Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania., Martino MA; Ascension St. Vincent's, Jacksonville, Florida; University of South Florida, Tampa, Florida, Gynecologic oncologist., Patel MD; Mayo Clinic Arizona, Phoenix, Arizona; IF Committee., Patlas MN; Department of Medical Imaging, Temerty Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada., Revzin MA; Yale University School of Medicine, New Haven, Connecticut; Committee on Emergency Radiology-GSER., VanBuren W; Mayo Clinic, Rochester, Minnesota., Yashar CM; University of California, San Diego, San Diego, California; Commission on Radiation Oncology., Kang SK; Specialty Chair, New York University Medical Center, New York, New York.
Publikováno v:
Journal of the American College of Radiology : JACR [J Am Coll Radiol] 2024 Jun; Vol. 21 (6S), pp. S79-S99.
Autor:
Bogani G; Gynecological Oncology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy. Electronic address: giorgiobogani@yahoo.it., Monk BJ; GOG Foundation, Florida Cancer Specialists and Research Institute, West Palm Beach., Powell MA; Division of Gynecologic Oncology, Washington University School of Medicine, St. Louis., Westin SN; University of Texas MD Anderson Cancer Center, Houston., Slomovitz B; Division of Gynecologic Oncology, Mount Sinai Medical Center, Miami Beach., Moore KN; Stephenson Cancer Center at the University of Oklahoma Medical Center, Oklahoma., Eskander RN; Division of Gynecologic Oncology, Department of Obstetrics, Gynecology, and Reproductive Sciences, University of California, San Diego, Rebecca and John Moores Cancer Center, La Jolla, USA., Raspagliesi F; Gynecological Oncology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy., Barretina-Ginesta MP; Medical Oncology, Catalan Institute of Oncology, Hospital Universitari Dr. Josep Trueta, Girona; Precision Oncology Group (OncoGIR-Pro), Institut d'Investigació Biomèdica de Girona (IDIBGI), Girona; Department of Medical Sciences, Girona University, Girona, Spain., Colombo N; Gynecologic Oncology Program, European Institute of Oncology IRCCS, Milan; Department of Medicine and Surgery, University of Milan-Bicocca, Milan, Italy., Mirza MR; Nordic Society of Gynecological Oncology and Rigshospitalet-Copenhagen University Hospital, Copenhagen, Denmark.
Publikováno v:
Annals of oncology : official journal of the European Society for Medical Oncology [Ann Oncol] 2024 May; Vol. 35 (5), pp. 414-428. Date of Electronic Publication: 2024 Feb 29.
Autor:
Nishizaki D; Division of Hematology and Oncology, Department of Medicine, Center for Personalized Cancer Therapy, University of California San Diego, Moores Cancer Center, 3855 Health Sciences Drive, La Jolla, CA 92037, USA. Electronic address: dnishizaki@health.ucsd.edu., Eskander RN; Division of Gynecologic Oncology, Department of Obstetrics, Gynecology and Reproductive Sciences, Center for Personalized Cancer Therapy, University of California San Diego, Moores Cancer Center, La Jolla, CA, USA.
Publikováno v:
Surgical oncology clinics of North America [Surg Oncol Clin N Am] 2024 Apr; Vol. 33 (2), pp. 279-291. Date of Electronic Publication: 2023 Dec 23.
Autor:
Nishizaki D; Center for Personalized Cancer Therapy and Division of Hematology and Oncology, Department of Medicine, University of California San Diego, Moores Cancer Center, La Jolla. Electronic address: dnishizaki@health.ucsd.edu., Kurzrock R; MCW Cancer Center and Genomic Sciences and Precision Medicine Center, Medical College of Wisconsin, Milwaukee, USA; WIN Consortium, Paris, France., Miyashita H; Dartmouth Cancer Center, Hematology and Medical Oncology, Lebanon., Adashek JJ; Department of Oncology, The Sidney Kimmel Comprehensive Cancer Center, The Johns Hopkins Hospital, Baltimore., Lee S; Center for Personalized Cancer Therapy and Division of Hematology and Oncology, Department of Medicine, University of California San Diego, Moores Cancer Center, La Jolla., Nikanjam M; Center for Personalized Cancer Therapy and Division of Hematology and Oncology, Department of Medicine, University of California San Diego, Moores Cancer Center, La Jolla., Eskander RN; Center for Personalized Cancer Therapy and Division of Gynecologic Oncology, Department of Obstetrics, Gynecology, and Reproductive Sciences, University of California San Diego, Moores Cancer Center, La Jolla., Patel H; Center for Personalized Cancer Therapy and Division of Hematology and Oncology, Department of Medicine, University of California San Diego, Moores Cancer Center, La Jolla., Botta GP; Center for Personalized Cancer Therapy and Division of Hematology and Oncology, Department of Medicine, University of California San Diego, Moores Cancer Center, La Jolla., Nesline MK; OmniSeq Inc., Buffalo., Pabla S; OmniSeq Inc., Buffalo., Conroy JM; OmniSeq Inc., Buffalo., DePietro P; OmniSeq Inc., Buffalo., Sicklick JK; Division of Surgical Oncology, Department of Surgery, Center for Personalized Cancer Therapy, University of California San Diego, La Jolla, USA., Kato S; Center for Personalized Cancer Therapy and Division of Hematology and Oncology, Department of Medicine, University of California San Diego, Moores Cancer Center, La Jolla. Electronic address: smkato@health.ucsd.edu.
Publikováno v:
ESMO open [ESMO Open] 2024 Apr; Vol. 9 (4), pp. 102942. Date of Electronic Publication: 2024 Mar 18.
Autor:
Wilson EM; Moores Cancer Center, Division of Gynecologic Oncology, Department of Obstetrics, Gynecology, and Reproductive Sciences, University of California San Diego, San Diego, CA 92037, USA., Eskander RN; Moores Cancer Center, Division of Gynecologic Oncology, Department of Obstetrics, Gynecology, and Reproductive Sciences, University of California San Diego, San Diego, CA 92037, USA., Binder PS; Moores Cancer Center, Division of Gynecologic Oncology, Department of Obstetrics, Gynecology, and Reproductive Sciences, University of California San Diego, San Diego, CA 92037, USA.
Publikováno v:
Cancers [Cancers (Basel)] 2024 Feb 13; Vol. 16 (4). Date of Electronic Publication: 2024 Feb 13.
Autor:
Eskander RN; University of California, San Diego, Rebecca and John Moores Cancer Center, San Diego, California.
Publikováno v:
Clinical advances in hematology & oncology : H&O [Clin Adv Hematol Oncol] 2024 Jan-Feb; Vol. 22 (1), pp. 28-30.
Autor:
Jou J; Division of Gynecologic Oncology, Oregon Health and Sciences University, Knight Cancer Institute, Portland, Oregon., Kato S; Division of Hematology & Oncology and Center for Personalized Cancer Therapy, University of California San Diego, Moores Cancer Center, La Jolla, California., Miyashita H; Department of Hematology & Oncology, Dartmouth Cancer Center, Lebanon, New Hampshire., Thangathurai K; Department of Physical Science, University of Vavuniya, Sri Lanka., Pabla S; OmniSeq, Inc. (a Labcorp subsidiary), Buffalo, New York., DePietro P; OmniSeq, Inc. (a Labcorp subsidiary), Buffalo, New York., Nesline MK; OmniSeq, Inc. (a Labcorp subsidiary), Buffalo, New York., Conroy JM; OmniSeq, Inc. (a Labcorp subsidiary), Buffalo, New York., Rubin E; The Shraga Segal Department for Microbiology, Immunology and Genetics, Ben-Gurion University of the Negev, Beer Sheva, Israel., Eskander RN; Division of Gynecologic Oncology, University of California San Diego, Moores Cancer Center, La Jolla, California., Kurzrock R; WIN Consortium and Medical College of Wisconsin Cancer Center, Milwaukee, Wisconsin.
Publikováno v:
Molecular cancer therapeutics [Mol Cancer Ther] 2023 Nov 01; Vol. 22 (11), pp. 1352-1362.